UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2017-05, Vol.18 (5), p.663-671

2017

Volltextzugriff (PDF)

Water sanitation, hygiene and the prevalence of diarrhea in the rural areas of the delta region of Myanmar

Journal of water and health, 2022-01, Vol.20 (1), p.149-156

2022

Volltextzugriff (PDF)

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

Journal of thoracic oncology, 2022-02, Vol.17 (2), p.289-308

2022

Volltextzugriff (PDF)

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer

Cancer science, 2017-05, Vol.108 (5), p.1000-1006

2017

Volltextzugriff (PDF)

Sex determination using color fundus parameters in older adults of Kumejima population study

Graefe's archive for clinical and experimental ophthalmology, 2023-08, Vol.261 (8), p.2411-2419

2023

Volltextzugriff (PDF)

Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns

Investigative ophthalmology & visual science, 2018-12, Vol.59 (15), p.5717-5725

2018

Volltextzugriff (PDF)

KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer

Cancer science, 2019-03, Vol.110 (3), p.1012-1020

2019

Volltextzugriff (PDF)

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

The lancet oncology, 2009-02, Vol.10 (2), p.115-124

2009

Volltextzugriff (PDF)

Comparison Between Clopidogrel and Prasugrel Associated With CYP2C19 Genotypes in Patients Receiving Percutaneous Coronary Intervention in a Japanese Population

Circulation Journal, 2020/08/25, Vol.84(9), pp.1575-1581

2020

Volltextzugriff (PDF)

Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention

Circulation Journal, 2023/05/25, Vol.87(6), pp.755-763

2023

Volltextzugriff (PDF)

Relationship between fundus sex index obtained using color fundus parameters and body height or axial length in the Kumejima population

Japanese journal of ophthalmology, 2024-09, Vol.68 (5), p.586-593

2024

Volltextzugriff (PDF)

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)

Clinical lung cancer, 2019-11, Vol.20 (6), p.469-476.e1

2019

Volltextzugriff (PDF)

Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation

The American journal of cardiology, 2022-01, Vol.162, p.13-23

2022

Volltextzugriff (PDF)

Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides

International Heart Journal, 2020/01/31, Vol.61(1), pp.77-82

2020

Volltextzugriff (PDF)

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis

Cancer science, 2019-09, Vol.110 (9), p.2884-2893

2019

Volltextzugriff (PDF)

Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study

Japanese journal of clinical oncology, 2021-08, Vol.51 (8), p.1261-1268

2021

Volltextzugriff (PDF)

A Case of Atypical Carcinoid: Harboring Variant 3a/b EML4–ALK Rearrangement

Journal of thoracic oncology, 2015-10, Vol.10 (10), p.e104-e106

2015

Volltextzugriff (PDF)

MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic Adenocarcinoma

Annals of surgical oncology, 2010-12, Vol.17 (12), p.3120-3128

2010

Volltextzugriff (PDF)

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

Cancer science, 2020-12, Vol.111 (12), p.4480-4489

2020

Volltextzugriff (PDF)

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies

Japanese journal of clinical oncology, 2021-01, Vol.51 (1), p.106-113

2021

Volltextzugriff (PDF)

MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis

Surgery, 2011-11, Vol.150 (5), p.916-922

2011

Volltextzugriff (PDF)

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

Cancer science, 2021-12, Vol.112 (12), p.5000-5010

2021

Volltextzugriff (PDF)

1 – 25 von 1.991

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.757)
Mit Volltextzugriff
(1.647)

Publikationsform

Sprache

Englisch
(1.813)
Japanisch
(208)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

Anticoagulation Therapy for Venous Thromboembolism in the Real World　― From the COMMAND VTE Registry

Water sanitation, hygiene and the prevalence of diarrhea in the rural areas of the delta region of Myanmar

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer

Sex determination using color fundus parameters in older adults of Kumejima population study

Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention

Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns

KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

Comparison Between Clopidogrel and Prasugrel Associated With CYP2C19 Genotypes in Patients Receiving Percutaneous Coronary Intervention in a Japanese Population

Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention

Relationship between fundus sex index obtained using color fundus parameters and body height or axial length in the Kumejima population

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)

Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation

Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis

Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study

A Case of Atypical Carcinoid: Harboring Variant 3a/b EML4–ALK Rearrangement

MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic Adenocarcinoma

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study

MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

Aktive Filter

Suchergebnisse filtern